Preventing Anthracycline-Induced Cardiotoxicity Using Functional Genomics and Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes-Reference-Cited by-同舟云学术

Preventing Anthracycline-Induced Cardiotoxicity Using Functional Genomics and Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes

Published:2022-01-25 Issue:4 Volume:145 Page:295-298
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Lo Sardo Valentina¹²,Kamp Timothy J.¹²³^ORCID

Affiliation:

1. Department of Cell and Regenerative Biology (V.LS., T.J.K.), University of Wisconsin-Madison.

2. Stem Cell and Regenerative Medicine Center (V.LS., T.J.K.), University of Wisconsin-Madison.

3. Department of Medicine (T.J.K.), University of Wisconsin-Madison.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference9 articles.

1. Pfizer Inc. TOTECT (dexrazoxane). U.S. Food and Drug Administration website. Revised April 2014. Accessed December 12 2021. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022025s019lbl.pdf

2. Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors.;Bansal N;Cardiooncology,2019

3. Validating the pharmacogenomics of chemotherapy-induced cardiotoxicity: What is missing?

4. Pharmacogenomic screening for anthracycline‐induced cardiotoxicity in childhood cancer

5. Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human Stem Cells for Cardiac Disease Modeling and Preclinical and Clinical Applications—Are We on the Road to Success?;Cells;2023-06-27

2. Modulation of lncRNA links endothelial glycocalyx to vascular dysfunction of tyrosine kinase inhibitor;Cardiovascular Research;2023-06-02

3. Genetic Susceptibility and Mechanisms Underlying the Pathogenesis of Anthracycline-Associated Cardiotoxicity;Oxidative Medicine and Cellular Longevity;2022-08-03